JSM Activity #57

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
57 Applied Session Sun, 8/3/03, 4:00 PM - 5:50 PM H-Continental Ballroom 1
Clinical Trials: Decisions, End-points and Risk Assessment Analysis - Contributed - Papers
Biopharmaceutical Section
Chair(s): Alan H. Hartford, North Carolina State University
     4:05 PM   Measurement of Change — Timothy W. Victor, AstraZeneca LP; Richard E. White, AstraZeneca LP
     4:20 PM   An Overview of Some Strategies for Dealing with Composite Endpoints in Clinical Trials — Abdul J. Sankoh, Aventis Pharmaceuticals, Inc.
     4:35 PM   Evaluating Multiple Endpoints Collectively — Qian Li, Food and Drug Administration
     4:50 PM   Ethical Issues in Data Monitoring of Clinical Trials — James F. Ward, ICOS Corporation
     5:05 PM   Risk Assessment Modeling of a Clinical Trial Program with Multiple Endpoints and Replication Studies — Daniel Z. Wang, Johnson & Johnson Pharmaceutical Research and Development, LLC
     5:20 PM   Decision Analysis of Phase II Clinical Trials — Jie Zhang, Novartis Pharmaceuticals
     5:35 PM   Quality of Life Endpoint in Oncology Drug Trials--Issues and Statistical Modeling — Rajeshwari Sridhara, Food and Drug Administration; Gang Chen, Food and Drug Administration; George Y.H. Chi, Food and Drug Administration
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003